C
Celldex Therapeutics, Inc. (CLDX)
NCM – Real vaqt narxi. Valyuta: USD
30.30
-1.45 (-4.57%)
Yopilishda: Mar 27, 2026, 4:00 PM EDT
30.69
+0.39 (1.29%)
Bozordan keyin: Mar 27, 2026, 4:59 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
NCM – Real vaqt narxi. Valyuta: USD
30.30
-1.45 (-4.57%)
Yopilishda: Mar 27, 2026, 4:00 PM EDT
30.69
+0.39 (1.29%)
Bozordan keyin: Mar 27, 2026, 4:59 PM EDT
This stock has a consensus price target of $50.17 based on the ratings of 14 analysts. The high is $90.00 and the low is $24.00.
| Maqsad | Min. maqsadli narx | O‘rtacha maqsadli narx | Maks. maqsadli narx |
|---|---|---|---|
| Narx | $ 24 | $ 50.17 | $ 90 |
| O’zgarish | -20.79% | 65.58% | 197.03% |
| Sana | O‘sish/pasayish potensiali | Tahlilchi firmasi | Maqsadli narx | Reyting o‘zgarishi | Reyting |
|---|---|---|---|---|---|
| 2026-03-02 | 12.21% | Goldman Sachs | $30 → $34 | Maintains | Neutral |
| 2026-02-26 | 124.42% | Stifel | $58 → $68 | Reiterates | Buy |
| 2025-12-17 | -20.79% | Barclays | $21 → $24 | Maintains | Underweight |
| 2025-11-11 | -30.69% | Barclays | $25 → $21 | Maintains | Underweight |
| 2025-10-21 | 58.42% | Mizuho | $48 | Initiates Coverage On | Outperform |